🔊 SOUND ON Transforming the patient voice into meaningful action For 20 years, PatientView has been capturing the authentic voice of patient groups to help pharmaceutical companies improve their relationships with patient groups.

‘Patient Groups: A Seat at the Pricing Table’ is now available The latest global research explores how patient groups are participating in pricing, reimbursement & access discussions worldwide. Visit patientview.com or contact [email protected] to find out more.

Tomorrow, PatientView will release research that examines the actions & advocacy of patient groups to gain access to medicines. ‘Patient Groups: A Seat at the Pricing Table’, will draw on insights from 2,262 patient groups. Contact [email protected] for more info

PatientView’s latest Corporate Reputation of Pharma 2025 reports reveal how 282 patient groups across ANZ, China, & Japan perceive the pharma industry. Separate reports are available for ANZ, China, and Japan. For further information, visit patient-view.com/press-relea…

Today, PatientView has released the Neurology Edition of ‘The Corporate Reputation of Pharma, 2025-2026’, alongside two separate reports covering Neurodegenerative Conditions and Multiple Sclerosis (MS). More information can be found in the press release tinyurl.com/bp6myhwx

The Corporate Reputation of Pharma 2025/26, Cancer Edition is now available. The report captures the perspectives of 505 Cancer patient groups & features the performance of 31 pharma and biotech companies. Read the Press Release: tinyurl.com/bp6myhwx

How effective are 4 key pharma companies at involving patients or patient groups in the co-design of Real-World Evidence studies? This is Question 3ii of the freely available ‘What Companies Say, 2025-2026’ PatientView report. Access here:  tinyurl.com/3cckuapz

𝗪𝗼𝗿𝗹𝗱 𝗣𝗿𝗼𝘀𝘁𝗮𝘁𝗲 𝗖𝗮𝗻𝗰𝗲𝗿 𝗗𝗮𝘆: 𝗪𝗵𝘆 𝗴𝗹𝗼𝗯𝗮𝗹 𝗮𝗰𝘁𝗶𝗼𝗻 𝗶𝘀 𝗻𝗲𝗲𝗱𝗲𝗱 Prostate cancer's the most commonly diagnosed cancer in men in 100+ countries, yet approaches to screening, diagnosis, & care remain inconsistent. Read more:tinyurl.com/2p9jafta

Today, the Corporate Reputation of Pharma 2025/26, Canada Edition has been published. For more information, including industry-wide findings and the top-ranking pharma companies in Canada, read the press release: patient-view.com/press-relea…

ViiV Healthcare has ranked #1 for the 13th consecutive year in the PatientView Corporate Reputation of Pharma survey. Given the company’s consistently high rankings, we recently spoke with Ama Appiah, Patient Affairs Lead, at ViiV Healthcare. Read the Q&A: tinyurl.com/yskv2mxf

“How do four key pharma companies address R&D demands from patient groups?” Find answers to this question in 'What Companies Say 2025-2026', with contributions from Boehringer Ingelheim, Novartis, Servier, and ViiV Healthcare. Access the publication here: tinyurl.com/39fkur6h

Friday 15th – USA press release The Corporate Reputation of Pharma 2025/26 - USA Edition is now available To learn more about the changes in the corporate reputation of the US pharma industry and individual pharma companies, read the press release: patient-view.com/press-relea…

This Thursday, PatientView will release The Corporate Reputation of Pharma 2025/26 – Global Edition. Results will reveal how the pharma industry and pharma companies have performed in 2025, drawing on 2,403 patient group perspectives. Contact [email protected] for details

This is a final call to patient groups! Today is the last day to participate in the PatientView Corporate Reputation of Pharma 2025 Survey. Help us shape the future of healthcare and participate! Access the survey in your preferred language: patient-view.com/corporate-r…

There's just 1 day left to complete the PatientView Corporate Reputation of Pharma 2025 Survey. By filling out the short survey, you can help strengthen the patient voice & shape the future of healthcare. Complete the survey in your preferred language: tinyurl.com/5x5pj2pa

We're calling on patient groups - the clock is ticking! There are only two days left to complete the PatientView Corporate Reputation of Pharma 2025 Survey. This is your chance to be part of the movement, complete the survey here: patient-view.com/corporate-r…

This is a call to patient groups, there are just 3 days left to complete the PatientView Corporate Reputation of Pharma 2025 Survey! Your insights are powerful, and they deserve to be heard. Complete the short survey here: patient-view.com/corporate-r…

Patient groups, the 1-week countdown has officially begun! You have just 7 days left to complete the PatientView Corporate Reputation of Pharma 2025 survey. Make sure you take part before it’s too late! Here is the link to the survey: patient-view.com/corporate-r…

PatientView sends warm wishes to those celebrating the #LanternFestival. It's now the Year of the Fire Horse, and we encourage patient groups to drive positive change by participating in the Corporate Reputation of Pharma survey before 16th March: patient-view.com/corporate-r…

#WorldObesityDay Obesity is a complex, chronic condition affecting millions. Patient groups play a huge role in reducing stigma & advocating for better care. Show pharma how they need to improve by completing the 2025 Corporate Reputation of Pharma Survey tinyurl.com/mr2ub5sf

Patient groups, you have until 16th March to complete the PatientView Corporate Reputation of Pharma Survey! How long does it take? Just a few minutes! Why your voice matters: Your lived experience is essential to driving change. Complete the survey today: tinyurl.com/5x5pj2pa